Transcarent to Acquire Accolade for $621M, Uniting Healthcare Advocacy and AI-Powered Solutions
Key Highlights Transcarent to acquire Accolade for $7.03/share, a $621M deal approved by both Boards. Unified platform to…
Browsing Tag
David McMullin
1 post